Synthesis and Biological Evaluation of Novel Ramalin Derivatives as Multi-Target Agents for Alzheimer’s Disease
Molecules · 2025
DOI: 10.3390/molecules30092030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Tai Kyoung Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: CRYOTECH Inc., 2F-211-3, 71 Mieumsandan 5-ro 41beon-gil, Gangseo-gu, Busan 46744, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Polar Research Institute, Ministry of Oceans and Fisheries.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by cognitive decline, oxidative stress, neuroinflammation, amyloid-beta (Aβ) accumulation, and tau protein hyperphosphorylation. In this study, we synthesized novel Ramalin derivatives and evaluated their therapeutic potential against AD, focusing on antioxidant, anti-inflammatory, and neuroprotective activities. RA-2OMe, RA-4OMe, RA-2CF3, and RA-4OCF3 showed strong antioxidant effects, while RA-2OMe exhibited potent NO and NLRP3 inhibition (~20%). RA-NAP, RA-PYD, and RA-2Q showed moderate anti-inflammatory activity. BACE-1 inhibition was significant in RA-3CF3, RA-NAP, and RA-PYD, with IC50 values lower than that of positive control, indicating greater inhibitory potency. RA-NAP and RA-PYD effectively inhibited both Aβ and tau aggregation, highlighting their multi-target potential for AD therapy. These findings indicate that Ramalin derivatives exhibit potential for multi-target activity in AD treatment. However, further studies on their pharmacokinetics, in vivo efficacy, and long-term safety are required to confirm their therapeutic applicability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CRYOTECH Inc., 2F-211-3, 71 Mieumsandan 5-ro 41beon-gil, Gangseo-gu, Busan 46744, Republic of Korea.
- Division of Polar Life Sciences, Korea Polar Research Institute, Incheon 21990, Republic of Korea.
- Department of Marine Sciences, Incheon National University, Incheon 22012, Republic of Korea.
- School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- Department of Plant Biotechnology, Korea University, Seoul 02841, Republic of Korea.
- College of Pharmacy, Wonkwang University, Iksan 54538, Republic of Korea.
ORCID-Profile: Ju-Mi Hong, Yongeun Cho, Jeongmi Lee, Jaewon Kim, Il-Chan Kim, Se Jong Han, Dong-Gyu Jo, Joung Han Yim
Förderung
- Korea Polar Research Institute
- Ministry of Oceans and Fisheries
Zitieren
APA
Kim, T. K., Hong, J. M., Cho, Y., Jeon, Y., Cho, H., Lee, J., Kim, J., Kim, K. H., Kim, I. C., Han, S. J., Oh, H., Jo, D. G., & Yim, J. H. (2025). Synthesis and Biological Evaluation of Novel Ramalin Derivatives as Multi-Target Agents for Alzheimer’s Disease. Molecules. https://doi.org/10.3390/molecules30092030
Vancouver
Kim TK, Hong JM, Cho Y, Jeon Y, Cho H, Lee J, et al. Synthesis and Biological Evaluation of Novel Ramalin Derivatives as Multi-Target Agents for Alzheimer’s Disease. Molecules. 2025. doi:10.3390/molecules30092030
BibTeX
@article{Kim2025,
author = {Kim, Tai Kyoung and Hong, Ju-Mi and Cho, Yongeun and Jeon, Yeji and Cho, Heewon and Lee, Jeongmi and Kim, Jaewon and Kim, Kyung Hee and Kim, Il-Chan and Han, Se Jong and Oh, Hyuncheol and Jo, Dong-Gyu and Yim, Joung Han},
title = {Synthesis and Biological Evaluation of Novel Ramalin Derivatives as Multi-Target Agents for Alzheimer’s Disease},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30092030}
}
EUVIMED